- Visibility 305 Views
- Downloads 587 Downloads
- Permissions
- DOI 10.18231/j.ijcaap.2025.017
-
CrossMark
- Citation
A short communication on digital and smart pharmacology: A new frontier in personalized medicine
Digital and smart pharmacology is redefining the landscape of healthcare by integrating information technology, artificial intelligence, and biomedical sensors into pharmacological processes. These advancements enhance drug adherence, optimize dosage regimens, and facilitate real-time therapeutic monitoring. This review outlines the current state of digital pharmacology, focusing on digital pills, wearable biosensors, mobile health applications, and AI-driven drug management. While the field presents vast opportunities for precision medicine, challenges such as data privacy, regulatory hurdles, and technology accessibility must be addressed for widespread adoption.
Keywords: Digital pharmacology, Smart drug delivery, Personalized medicine, Digital therapeutics, Artificial intelligence in healthcare, Wearable biosensors.
References
- Bush WS, Cooke Bailey JN, Beno MF, Crawford DC. Bridging the Gaps in personalized medicine value assessment: A review of the need for outcome metrics across stakeholders and scientific disciplines. Public Health Genomics. 2019;22(1-2):16–24.
- Shawaqfeh MS, Al Bekairy AM, Al-Azayzih A, Alkatheri AA, Qandil AM, Obaidat AA, et al. Pharmacy students perceptions of their distance online learning experience during the COVID-19 pandemic: A cross-sectional survey study. J Med Educ Curric Dev. 2020;7:2382120520963039.
- Lee CY, Lee SWH. REVIEW: Impact of the educational technology use in undergraduate pharmacy teaching and learning – A systematic review. Pharm Educ. 2021;21:159–68.
- Strawbridge J, Hayden JC, Robson T, Flood M, Cullinan S, Lynch M, et al. Educating pharmacy students through a pandemic: 118 Dubey / IP International Journal of Comprehensive and Advanced Pharmacology 2025;10(2):115–118 Reflecting on our COVID-19 experience. Res Social Adm Pharm. 2022;18(7):3204–9.
- Serretti A. The present and future of precision medicine in psychiatry: Focus on clinical psychopharmacology of antidepressants. Clin Psychopharmacol Neurosci. 2018;16(1):1–6.
- Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391(10128):1367–77.
- Topol E. Deep medicine: how artificial intelligence can make healthcare human again. London: Hachette UK; 2019.
- Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2(10):719–31.
- Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data. 2016;3:160026.
- Fitzpatrick KK, Darcy A, Vierhile M. Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (woebot): a randomized controlled trial. JMIR Ment Health. 2017;4(2):e19.
- Pear Therapeutics Inc. reSET-O: clinician directions for use [Internet]. Boston (MA): Pear Therapeutics Inc.; 2020 [cited 2025 Jul 17].
- Benedetto V, Mainardi V, Pennucci F, Damone A, Ciuti G, Nuti S. Digital health for environmentally sustainable cancer screening. npj Digit Med. 2025;8. https://doi.org/10.1038/s41746-025-01561-x
[Google Scholar] - Björnsson B, Borrebaeck C, Elander N, Gasslander T, Gawel DR, Gustafsson M, et al. Digital twins to personalize medicine. Genome Med. 2019;12(1):4.
- Rothman B, Slomkowski M, Speier A, Rush AJ, Trivedi MH, Lawson E, et al. Evaluating the efficacy of a digital therapeutic (ct- 152) as an adjunct to antidepressant treatment in adults with major depressive disorder: Protocol for the MIRAI remote study. JMIR Res Protoc. 2024;13:e56960.
- US Food and Drug Administration. Digital Health Center of Excellence [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2025 [cited 2025 Jul 2]. Available from: https://www.fda.gov/medical-devices/digital-health-center- excellence.
How to Cite This Article
Vancouver
Dubey S. A short communication on digital and smart pharmacology: A new frontier in personalized medicine [Internet]. IP Int J Compr Adv Pharmacol. 2025 [cited 2025 Oct 03];10(2):115-118. Available from: https://doi.org/10.18231/j.ijcaap.2025.017
APA
Dubey, S. (2025). A short communication on digital and smart pharmacology: A new frontier in personalized medicine. IP Int J Compr Adv Pharmacol, 10(2), 115-118. https://doi.org/10.18231/j.ijcaap.2025.017
MLA
Dubey, Shivam. "A short communication on digital and smart pharmacology: A new frontier in personalized medicine." IP Int J Compr Adv Pharmacol, vol. 10, no. 2, 2025, pp. 115-118. https://doi.org/10.18231/j.ijcaap.2025.017
Chicago
Dubey, S.. "A short communication on digital and smart pharmacology: A new frontier in personalized medicine." IP Int J Compr Adv Pharmacol 10, no. 2 (2025): 115-118. https://doi.org/10.18231/j.ijcaap.2025.017